Business
Avicanna Secures Canadian Cannabinoid Research Licence at its Headquarters in Toronto's Discovery District
Avicanna Secures Canadian Cannabinoid Research Licence at its Headquarters in Toronto's Di...
About this update from Avicanna Inc
[{"type":"text","content":"\n\n\n\nAvicanna Secures Canadian Cannabinoid Research Licence at its Headquarters in Toronto's Discovery District\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, Aug. 19, 2019\n\n\n\n/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ \n TORONTO, Aug. 19, 2019 /CNW/ - Avicanna Inc. (\"Avicanna\" or the \"Company\") a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that it has received a research licence (the \"Research Licence\") from Health Canada. The Research Licence will allow Avicanna's research and development team to work with cannabinoid-based formulations and advanced pharmaceutical drug development at Avicanna's research and development headquarters located at the MaRS Discovery District in Toronto. \n\n \n \n\n \nAras Azadian, Chief Executive Officer of Avicanna commented \"Attaining this licence will allow Avicanna's team of scientists to directly enhance and expedite research and development and intellectual property development projects while we concurrently execute via our ongoing collaborations, including with the University of Toronto, and at our subsidiaries' laboratories in Colombia. In this way, Avicanna has further fortified its leadership position in the cannabinoid-based pharmaceutical industry and will further leverage working with top Canadian researchers, clinicians and world class institutions, many of which are located meters away from the newly licensed lab.\" \nAbout Avicanna\nAvicanna is an Ontario corporation focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products through its two main business segments, cultivation and research and development.\nAvicanna's two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for...